Arvinas, Inc. SEC filings ARVN
Arvinas, Inc. has 602 filings in SEC EDGAR's recent list, going back to Oct 23, 2015. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Nov 3, 2026 | — |
| S-8 | Employee stock plan registration | Sep 28, 2026 | — |
| S-8 | Employee stock plan registration | Aug 31, 2026 | — |
| S-8 | Employee stock plan registration | Feb 24, 2026 | — |
| S-8 | Employee stock plan registration | Feb 11, 2025 | — |
| S-8 | Employee stock plan registration | Jun 27, 2024 | — |
| S-8 | Employee stock plan registration | Mar 18, 2024 | — |
| S-8 | Employee stock plan registration | Jan 16, 2024 | — |
| S-3ASR | Automatic shelf registration | Dec 8, 2023 | — |
| S-3ASR | Automatic shelf registration | Nov 7, 2023 | — |
| S-8 | Employee stock plan registration | Feb 24, 2023 | — |
| S-8 | Employee stock plan registration | Feb 28, 2022 | — |
| 424B5 | Prospectus supplement | Aug 6, 2021 | — |
| 424B5 | Prospectus supplement | Aug 6, 2021 | — |
| S-8 | Employee stock plan registration | Mar 1, 2021 | — |
| 424B5 | Prospectus supplement | Dec 16, 2020 | — |
| 424B5 | Prospectus supplement | Dec 14, 2020 | — |
| S-3ASR | Automatic shelf registration | Dec 14, 2020 | — |
| S-8 | Employee stock plan registration | Mar 16, 2020 | — |
| 424B5 | Prospectus supplement | Nov 7, 2019 | — |
| 424B5 | Prospectus supplement | Nov 6, 2019 | — |
| 424B3 | Prospectus | Oct 18, 2019 | — |
| 424B3 | Prospectus | Oct 11, 2019 | — |
| S-3 | Shelf registration | Oct 1, 2019 | — |
| S-3 | Shelf registration | Oct 1, 2019 | — |
| S-8 | Employee stock plan registration | May 10, 2019 | — |
| S-8 | Employee stock plan registration | Sep 27, 2018 | — |
| 424B4 | Prospectus | Sep 27, 2018 | — |
| S-1MEF | Filing | Sep 26, 2018 | — |
| S-1/A | Amended registration statement | Sep 14, 2018 | — |
| S-1 | Registration statement | Aug 30, 2018 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARVN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- Accelerated filer
- SEC CIK
- 1655759
- Former names
- ARVINAS INC. (until Oct 10, 2018); ARVINAS HOLDING COMPANY, LLC (until Sep 28, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.